Lv0
0 积分 2024-11-08 加入
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
2小时前
已完结
HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study
4天前
已完结
HER2-Positive Metastatic Colorectal Cancer
4天前
已完结
Abstract PO3-16-12: European real-world experience of patients with HER2+ advanced/metastatic breast cancer accessing trastuzumab deruxtecan through a named patient program: first interim analysis of EUROPA T-DXd
2个月前
已完结
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study
2个月前
已完结
皖公网安备34019202002308
